We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current CHM market cap is 25.4M. The company's latest EPS is AUD -0.0306 and P/E is -0.98.
Year End 30 June 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
Total Revenue | 0 | 0 | 2.62M | 4.51M |
Operating Income | -64k | -14.85M | -14.57M | -24.98M |
Net Income | -64k | -15.11M | -15.9M | -25.92M |
Year End 30 June 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
Total Assets | 0 | 36.51M | 34.88M | 22.38M |
Total Liabilities | 64k | 11.37M | 9.17M | 16.72M |
Total Equity | -64k | 25.13M | 25.71M | 5.66M |
Year End 30 June 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
Operating | -34k | -8.84M | -13.15M | -16.31M |
Investing | N/A | -5.3M | -577k | -112k |
Financing | 34k | 36.54M | 9.54M | 253k |
Market Cap | 25.4M |
Price to Earnings Ratio | -0.98 |
Price to Sales Ratio | 5.66 |
Price to Cash Ratio | 10.71 |
Price to Book Ratio | 4.49 |
Dividend Yield | - |
Shares Outstanding | 846.79M |
Average Volume (1 week) | 2.99M |
Average Volume (1 Month) | 2.33M |
52 Week Change | -55.22% |
52 Week High | 0.073 |
52 Week Low | 0.023 |
Spread (Intraday) | 0 (3.33%) |
Company Name | Chimeric Therapeutics Limited |
Address |
c/- the cfo solution melbourne, victoria 3053 |
Website | https://www.chimerictherapeutics.com |
Industry | noncomml resh organizations (8733) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions